Work

A surgical window trial evaluating medroxyprogesterone acetate with or without entinostat in endometrial cancer and validation of biomarkers of cellular response: An NRG Oncology study

Year: 2021

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/s0090-8258(21)00697-1

Authors: Linda Duska, Virginia Filiaci, Joan Walker, Laura Holman, Emily Hill, Richard Moore, Kari Ring, Michael Pearl, Carolyn Muller, Christina Kushnir, Heather Lankes, Megan Samuelson, Kelley Carrick, Anand Rajan KD, William Rodgers, Elise Kohn, Richard Piekarz, Kimberly Leslie

Institutions: University of Virginia, NRG Oncology, University of Oklahoma, University of Iowa, University of Rochester Medicine, University of Rochester, Stony Brook Medicine, University of New Mexico, Women's Cancer Center of Nevada, The University of Texas Southwestern Medical Center, NewYork–Presbyterian Hospital, National Cancer Institute

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3194949122

FWCI: 0.196

Cites:

Cited by: 1

Related to: 10